Search by Drug Name or NDC

    NDC 17156-0026-30 Myoview 1.38 mg/1 Details

    Myoview 1.38 mg/1

    Myoview is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Medi-Physics Inc. dba GE Healthcare. The primary component is TETROFOSMIN.

    Product Information

    NDC 17156-0026
    Product ID 17156-026_3475dd6d-4e62-4907-9c45-00845816577f
    Associated GPIs 94353080756400
    GCN Sequence Number 073529
    GCN Sequence Number Description kit for prep Tc-99m/tetrofosmn VIAL 1.38 MG INTRAVEN
    HIC3 A6W
    HIC3 Description CARDIOVASCULAR DIAGNOSTICS - RADIOACTIVE
    GCN 37953
    HICL Sequence Number 024544
    HICL Sequence Number Description KIT FOR THE PREPARATION OF TC-99M/TETROFOSMIN
    Brand/Generic Brand
    Proprietary Name Myoview
    Proprietary Name Suffix n/a
    Non-Proprietary Name Tetrofosmin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 1.38
    Active Ingredient Units mg/1
    Substance Name TETROFOSMIN
    Labeler Name Medi-Physics Inc. dba GE Healthcare
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020372
    Listing Certified Through 2025-12-31

    Package

    NDC 17156-0026-30 (17156002630)

    NDC Package Code 17156-026-30
    Billing NDC 17156002630
    Package 5 VIAL in 1 KIT (17156-026-30) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
    Marketing Start Date 2009-02-26
    NDC Exclude Flag N
    Pricing Information N/A